BioCryst (BCRX) Jumps Higher After Canceling Conference Appearance
Shares of BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) are flying higher this afternoon after updating on its website that they cancelled today's appearance at an Oppenheimer conference "due to recent developments". Speculators are betting on a takeover or major partnership. Shares are up 7.6% on heavier-than-normal volume.
BioCryst recently received emergency use authorization for the investigational anti-viral drug intravenous peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
You May Also Be Interested In
- OmniVision (OVTI) Volatility Up on Move Lower
- Celldex Therapeutics (CLDX) Announces 'High Response' CDX-011 Trial Data
- Vodafone (VOD) Volatility Pops Early, Shares Inch Higher
Create E-mail Alert Related Categories
FDA, Momentum Movers, Rumors, Trader TalkRelated Entities
EIM GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
